BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 28256366)

  • 1. Bone morphogenetic protein-2 loaded poly(D,L-lactide-co-glycolide) microspheres enhance osteogenic potential of gelatin/hydroxyapatite/β-tricalcium phosphate cryogel composite for alveolar ridge augmentation.
    Chang HC; Yang C; Feng F; Lin FH; Wang CH; Chang PC
    J Formos Med Assoc; 2017 Dec; 116(12):973-981. PubMed ID: 28256366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-engineered composite scaffold of poly(lactide-co-glycolide) and hydroxyapatite nanoparticles seeded with autologous mesenchymal stem cells for bone regeneration.
    Zhang B; Zhang PB; Wang ZL; Lyu ZW; Wu H
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):963-976. PubMed ID: 29119734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.
    Kempen DH; Lu L; Hefferan TE; Creemers LB; Maran A; Classic KL; Dhert WJ; Yaszemski MJ
    Biomaterials; 2008 Aug; 29(22):3245-52. PubMed ID: 18472153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of poly (lactide-co-glycolide) (PLGA)-coated beta-tricalcium phosphate on the healing of rat calvarial bone defects: a comparative study with pure-phase beta-tricalcium phosphate.
    Bizenjima T; Takeuchi T; Seshima F; Saito A
    Clin Oral Implants Res; 2016 Nov; 27(11):1360-1367. PubMed ID: 26748831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.
    Chen SH; Wang XL; Xie XH; Zheng LZ; Yao D; Wang DP; Leng Y; Zhang G; Qin L
    Acta Biomater; 2012 Aug; 8(8):3128-37. PubMed ID: 22543006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin.
    Xie XH; Wang XL; Zhang G; He YX; Leng Y; Tang TT; Pan X; Qin L
    J Tissue Eng Regen Med; 2015 Aug; 9(8):961-72. PubMed ID: 23255530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fibroblast growth factor-2.
    Yoshida T; Miyaji H; Otani K; Inoue K; Nakane K; Nishimura H; Ibara A; Shimada A; Ogawa K; Nishida E; Sugaya T; Sun L; Fugetsu B; Kawanami M
    J Periodontal Res; 2015 Apr; 50(2):265-73. PubMed ID: 24966062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2.
    Kim SS; Gwak SJ; Kim BS
    J Biomed Mater Res A; 2008 Oct; 87(1):245-53. PubMed ID: 18181112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteointegration of PLGA implants with nanostructured or microsized β-TCP particles in a minipig model.
    Kulkova J; Moritz N; Suokas EO; Strandberg N; Leino KA; Laitio TT; Aro HT
    J Mech Behav Biomed Mater; 2014 Dec; 40():190-200. PubMed ID: 25241283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical alveolar ridge preservation using small-sized particles of bone replacement graft in combination with a gelatin cryogel scaffold.
    Chang PC; Chang HC; Lin TC; Tai WC
    J Periodontol; 2018 Oct; 89(10):1221-1229. PubMed ID: 30039627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ridge Preservation After Maxillary Third Molar Extraction Using 30% Porosity PLGA/HA/β-TCP Scaffolds With and Without Simvastatin: A Pilot Randomized Controlled Clinical Trial.
    Noronha Oliveira M; Rau LH; Marodin A; Corrêa M; Corrêa LR; Aragones A; Magini RS
    Implant Dent; 2017 Dec; 26(6):832-840. PubMed ID: 28885317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of BMP-2-releasing gelatin/β-TCP sponges with autologous bone marrow for bone regeneration of X-ray-irradiated rabbit ulnar defects.
    Yamamoto M; Hokugo A; Takahashi Y; Nakano T; Hiraoka M; Tabata Y
    Biomaterials; 2015 Jul; 56():18-25. PubMed ID: 25934275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bone morphogenetic protein-2 delivery systems to induce supracrestal bone guided by titanium implants in the rabbit mandible.
    Wen B; Kuhn L; Charles L; Pendrys D; Shafer D; Freilich M
    Clin Oral Implants Res; 2016 Jun; 27(6):676-85. PubMed ID: 26183057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the biomaterials 3wt%-nanostrontium-hydroxyapatite-enhanced calcium phosphate cement (nanoSr-CPC) and nanoSr-CPC-incorporated simvastatin-loaded poly(lactic-co-glycolic-acid) microspheres in osteogenesis improvement: An explorative multi-phase experimental in vitro/vivo study.
    Masaeli R; Jafarzadeh Kashi TS; Dinarvand R; Rakhshan V; Shahoon H; Hooshmand B; Mashhadi Abbas F; Raz M; Rajabnejad A; Eslami H; Khoshroo K; Tahriri M; Tayebi L
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():171-83. PubMed ID: 27612702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsphere-based scaffolds encapsulating tricalcium phosphate and hydroxyapatite for bone regeneration.
    Gupta V; Lyne DV; Barragan M; Berkland CJ; Detamore MS
    J Mater Sci Mater Med; 2016 Jul; 27(7):121. PubMed ID: 27272903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-specific beta-tricalcium phosphate scaffold for customized alveolar ridge augmentation: a case report : Case Report: patient-specific β-TCP scaffold for alveolar ridge CBR.
    Schönegg D; Essig H; Al-Haj Husain A; Weber FE; Valdec S
    Int J Implant Dent; 2024 May; 10(1):21. PubMed ID: 38691252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of particle size on the in vivo degradation of poly(d,l-lactide-co-glycolide)/α-tricalcium phosphate micro- and nanocomposites.
    Bennett SM; Arumugam M; Wilberforce S; Enea D; Rushton N; Zhang XC; Best SM; Cameron RE; Brooks RA
    Acta Biomater; 2016 Nov; 45():340-348. PubMed ID: 27567963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on cytotoxicity of three-dimensional printed β-tricalcium phosphate loaded poly (lactide-co-glycolide) anti-tuberculosis drug sustained release microspheres and its effect on osteogenic differentiation of bone marrow mesenchymal stem cells].
    Gong D; Ma Y; Yang X; Xie W; Shao L; Zhen P
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Sep; 32(9):1131-1136. PubMed ID: 30129348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rhBMP-2 with PLGA/gelatin sponge type (PGS) carrier on alveolar ridge augmentation in dogs.
    Kawakatsu N; Oda S; Kinoshita A; Kikuchi S; Tsuchioka H; Akizuki T; Hayashi C; Kokubo S; Ishikawa I; Izumi Y
    J Oral Rehabil; 2008 Sep; 35(9):647-55. PubMed ID: 18482353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering.
    Ji Y; Xu GP; Zhang ZP; Xia JJ; Yan JL; Pan SH
    Ann Biomed Eng; 2010 Mar; 38(3):632-9. PubMed ID: 20049636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.